Hoth Therapeutics, Inc.
(NASDAQ : HOTH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.14%33.840.9%$1138.25m
JNJJohnson & Johnson 0.01%142.500.7%$1016.34m
BMYBristol-Myers Squibb Co. -1.17%57.431.0%$922.01m
MRKMerck & Co., Inc. 0.05%76.730.7%$787.68m
ABBVAbbVie, Inc. -1.18%96.781.9%$725.30m
LLYEli Lilly & Co. -1.84%163.391.1%$641.93m
AZNAstraZeneca Plc -0.40%53.761.2%$288.49m
RPRXRoyalty Pharma Plc -1.49%47.640.1%$203.76m
NVSNovartis AG -0.36%87.030.2%$143.34m
RGENRepligen Corp. -1.97%126.137.1%$115.34m
GSKGlaxoSmithKline Plc -1.14%39.910.2%$109.88m
NVONovo Nordisk A/S -0.26%65.440.1%$88.47m
RETAReata Pharmaceuticals, Inc. -1.10%154.403.4%$79.42m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -2.31%74.140.0%$67.56m
SNYSanofi -0.53%50.280.2%$63.74m

Company Profile

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.